Investor

Product offering will be expanded to help doctors in the UK and Germany deliver preventative care.

Legacy provides customers with a personalized digital report of their reproductive health within 24 hours of receiving a sample.

While the tech-enabled primary care provider set the initial pricing of its shares at $14 apiece, prices are climbing in the early hours of its IPO.

Report predicts growth will be driven by provider operations and alternative care companies.

The company's tech platform enables same-day prescription deliveries.

The Silicon Valley EHR vendor received “sponsorship” payments from unnamed pharmaceutical companies so that the latter’s marketing team could influence the design of CDS features, according to the Department of Justice.

The MobiHealthNews staff shares its thoughts on how HIPAA, investor funding, digital health commercialization and other focus areas will be changing over the course of the new year.

Formerly known as Enzyme Health, the company's strategy is comprised of two major avenues: telehealth staffing opportunities for practitioners, and a scalable telehealth platform for companies.

The Israeli company is developing a two-pronged offering comprised of an in-hospital device and a companion cloud software tool.

Blue Mesa's diabetes prevention program will now be rolled into a new offering called Virgin Pulse Transform.